Armata Pharmaceuticals, Inc. (ARMP) Misses Q4 EPS by 323c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q4 EPS of ($3.42), $3.23 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.48 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Lockheed Martin wins $83 million Army missile contract
• Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg